1. Home
  2. QURE vs CTKB Comparison

QURE vs CTKB Comparison

Compare QURE & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QURE
  • CTKB
  • Stock Information
  • Founded
  • QURE 1998
  • CTKB 1990
  • Country
  • QURE Netherlands
  • CTKB United States
  • Employees
  • QURE N/A
  • CTKB N/A
  • Industry
  • QURE Biotechnology: Pharmaceutical Preparations
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • QURE Health Care
  • CTKB Health Care
  • Exchange
  • QURE Nasdaq
  • CTKB Nasdaq
  • Market Cap
  • QURE 725.4M
  • CTKB 718.8M
  • IPO Year
  • QURE 2007
  • CTKB 2021
  • Fundamental
  • Price
  • QURE $17.27
  • CTKB $3.44
  • Analyst Decision
  • QURE Strong Buy
  • CTKB Hold
  • Analyst Count
  • QURE 10
  • CTKB 4
  • Target Price
  • QURE $37.20
  • CTKB $6.00
  • AVG Volume (30 Days)
  • QURE 1.4M
  • CTKB 1.5M
  • Earning Date
  • QURE 07-31-2025
  • CTKB 05-08-2025
  • Dividend Yield
  • QURE N/A
  • CTKB N/A
  • EPS Growth
  • QURE N/A
  • CTKB N/A
  • EPS
  • QURE N/A
  • CTKB N/A
  • Revenue
  • QURE $20,201,000.00
  • CTKB $197,050,000.00
  • Revenue This Year
  • QURE $27.16
  • CTKB $1.61
  • Revenue Next Year
  • QURE $248.21
  • CTKB $8.25
  • P/E Ratio
  • QURE N/A
  • CTKB N/A
  • Revenue Growth
  • QURE 6.30
  • CTKB N/A
  • 52 Week Low
  • QURE $3.73
  • CTKB $2.37
  • 52 Week High
  • QURE $19.18
  • CTKB $7.63
  • Technical
  • Relative Strength Index (RSI)
  • QURE 67.53
  • CTKB 60.92
  • Support Level
  • QURE $14.75
  • CTKB $2.37
  • Resistance Level
  • QURE $15.50
  • CTKB $3.53
  • Average True Range (ATR)
  • QURE 1.07
  • CTKB 0.19
  • MACD
  • QURE 0.16
  • CTKB 0.14
  • Stochastic Oscillator
  • QURE 93.40
  • CTKB 92.24

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: